Wilforol C exhibits significant immunosuppressive activity, making it a compound of interest in the development of therapies for autoimmune diseases and organ transplant rejection. It modulates T-cell activation and cytokine production, which helps in controlling overactive immune responses. Research also suggests potential anti-inflammatory effects, supporting its investigation in chronic inflammatory conditions. Due to its bioactive properties, Wilforol C is studied as a lead compound for novel immunomodulatory drugs.